Coronavirus impact: Govt keeps close tabs on drug supply, pricing

Govt keeping tabs on raw material stock, prices, and helping firms airlift APIs

Various government departments are keeping close tabs on the drug supply and pricing situation in India in the wake of global logistical crisis because of the coronavirus outbreak. 

While the pharma pricing regulator is monitoring the prices of bulk drugs quoted by traders, and watching the import of these ingredients, the drug regulator is monitoring the inventory of raw materials and drugs in the country. Meanwhile, the government has also started helping pharma companies that want raw materials to be airlifted from China. 

Industry sources said the National Pharmaceutical Pricing Authority (NPPA) has sought data from importers on key active pharmaceutical ingredients